Skip to main content

Table 2 Characteristics of implants and duration for which, they were in function

From: Levels of whole salivary advanced glycation end products and interleukin-17 and peri-implant clinical and radiographic status in patients with osteoporosis at 6-years’ follow-up

Parameters

Patients with osteoporosis

Patients without osteoporosis (controls)

P value

Implants (n)

33

29

0.22

Anterior maxilla

2 (6.1%)

4 (13.8%)

0.25

Anterior mandible

3 (9.1%)

2 (6.9%)

0.31

Posterior maxilla*

6 (18.2%)

7 (24.1%)

0.26

Posterior mandible*

22 (66.6%)

16 (55.2%)

0.19

Implant abutment connection

Platform-switched

Platform-switched

NA

Insertion torque (Newton centimeters)

30 to 35 NCm

30 to 35 NCm

NA

Implant diameter (in millimeters)

4 to 5 mm

4.1 to 5 mm

NA

Implant length (in millimeters)

12 to 14 mm

11 to 14 mm

NA

Implant prosthesis retention

*Cement retention (%)

14 (42.4%)

15 (51.7%)

0.31

Screw retention (%)

19 (57.6%)

14 (48.3%)

0.29

Duration for which, implants were in function (in years)

6.3 ± 0.27 years

6.6 ± 0.5 years

0.23

Depth of implant placement

Bone level

Bone level

NA

Implant supported dentures

None

None

NA

Implant supported dentures

None

None

NA

  1. NA Not applicable
  2. *Implants replacing missing premolars or molars